Platelet-rich Plasma Infiltration Versus Corticosteroid Infiltration (Prednisolone) in Treatment of Lumbar Facet Joint Syndrome

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

December 21, 2021

Primary Completion Date

May 16, 2024

Study Completion Date

May 16, 2024

Conditions
Low Back PainOsteoarthritis
Interventions
DRUG

Prednisolone

Patient will have 1 infiltration of 3mL to 5 mL corticosteroids on average distributed equally over all the posterior joints affected by arthritis phenomena.Lumbar facet joint injection with corticosteroids will be performed at inclusion

DRUG

Platelet-rich plasma

Patient will have 1 infiltration of 3mL to 5 mL of PRP on average distributed equally over all the posterior joints affected by arthritis phenomena.Lumbar facet joint injection with PRP will be performed at inclusion.

Trial Locations (1)

51092

Chu Reims, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT05105256 - Platelet-rich Plasma Infiltration Versus Corticosteroid Infiltration (Prednisolone) in Treatment of Lumbar Facet Joint Syndrome | Biotech Hunter | Biotech Hunter